Technical Update on the Big Biotech ETF

Still saddled with a three-month loss of 14%, the iShares Nasdaq Biotechnology ETF (NasdaqGM: IBB) has been noticeably less bad over the past month. The largest biotech ETF has traded modestly higher over that time. While IBB is behaving less poorly than it did in the back half of February and...